리드리스 페이스메이커 시장 규모, 점유율, 동향 분석 보고서 : 챔버별, 브랜드별, 최종 용도별, 지역별, 부문별 예측(2025-2033년)
Leadless Pacemakers Market Size, Share & Trends Analysis Report By Chambers, By Brands, By End Use, By Region, And Segment Forecasts, 2025 - 2033
상품코드
:
1888556
리서치사
:
Grand View Research
발행일
:
2025년 11월
페이지 정보
:
영문 140 Pages
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
샘플 요청 목록에 추가
리드리스 페이스메이커 시장 요약
세계의 리드리스 페이스메이커 시장 규모는 2024년에 8억 4,237만 달러로 추정되며, 2033년까지 16억 2,287만 달러에 달할 것으로 예측됩니다.
2025-2033년 CAGR 6.48%로 성장할 것으로 예상됩니다. 심장 질환 및 관련 위험 요인의 유병률 증가는 첨단 기기 기반 치료법에 대한 수요를 견인할 것으로 예상됩니다.
2025년 1월 옥스포드 학술지에 게재된 논문에 따르면, 전 세계적으로 심혈관질환의 연령 조정 발병률은 10만 명당 약 7,179명으로 추정되며, 이는 심장 질환의 심각하고 증가하는 부담을 강조하고 있습니다. 이러한 높은 유병률은 부정맥을 보다 안전하고 효과적으로 관리할 수 있는 혁신적인 페이싱 솔루션의 필요성을 높이고 있습니다. 리드 없는 심박조율기는 리드와 수술용 포켓을 제거함으로써 기존 심박조율기에 대한 최소침습적 대안을 제공함으로써 이 분야의 획기적인 발전으로 등장했습니다.
무심장 박동기는 지난 10년간 치료 옵션으로 자리 잡았으며, 기존 경정맥 박동기에 비해 큰 이점을 제공하고 있습니다. 2025년 4월 NCBI에 발표된 논문에 따르면, 리드선과 피하 주머니가 필요 없는 Micra와 Aveir와 같은 무연성 장치는 전극 이탈, 주머니 혈종, 기흉, 심내막염, 정맥 폐색과 같은 감염 및 장기적인 합병증의 위험을 크게 줄입니다. 평균 51개월 동안 1,809명의 환자를 추적 관찰한 Micra PAR 레지스트리 데이터에 따르면, 5년간 주요 합병증 발생률은 4.5%에 불과했으며, 대부분 이식 후 30일 이내에 발생했습니다. 주목할 만한 점은 기기 제거가 필요한 감염은 발생하지 않았으며, 시스템 수정도 주로 기기 업그레이드나 배터리 소모로 인한 시스템 수정이 극히 드물었다는 점입니다.
목차 제1장 조사 방법과 범위
제2장 리드리스 페이스메이커 시장 : 주요 요약
제3장 리드리스 페이스메이커 시장 변수, 동향, 범위
시장 계통 전망
시장 역학
세계의 리드리스 페이스메이커 : 시장 분석 툴
업계 분석 : Porter's Five Forces
PESTLE 분석
사례 연구 분석
환자 역학 및 채용 분석(비교 분석 : 2023년 대 2024년 대 2025년)
리드리스 페이스메이커 대상 환자 수(2023년 대 2024년 대 2025년)
실제로 리드리스 페이스메이커를 이식받은 환자 수(2023년 대 2024년 대 2025년)
비이식/금기 대상 환자 수(2023년 대 2024년 대 2025년)
안전성 및 합병증 발생률의 비교(2023년 대 2024년 대 2025년)
환자층 및 병존질환 구성(2023년 대 2024년 대 2025년)
리드리스 페이스메이커 시장 기술 동향
경쟁 요인과 전략
제4장 리드리스 페이스메이커 시장 부문 분석 : 챔버별(2021-2033년)
정의와 범위
챔버 다른 시장 점유율 분석, 2024년 및 2033년
세계의 리드리스 페이스메이커 시장 : 챔버별, 2021-2033년
리드리스 페이스메이커 시장 규모와 예측 : 챔버별, 2021-2033년
리드리스 페이스메이커 시장 규모와 예측 : 챔버별, 수량별, 2021-2033년(단위 : 천대)
제5장 리드리스 페이스메이커 시장 부문 분석 : 브랜드별(2021-2033년)
정의와 범위
브랜드별 시장 점유율 분석, 2024년 및 2033년
세계의 리드리스 페이스메이커 시장 : 브랜드 전망별
리드리스 페이스메이커 시장 규모와 예측 : 브랜드별, 2021-2033년
리드리스 페이스메이커 시장 규모와 예측 : 2021-2033년(단위 : 천대)
시장 규모 및 예측 및 동향 분석(2021-2033년)
제6장 리드리스 페이스메이커 시장 부문 분석 : 최종 용도별(2021-2033년)
정의와 범위
최종 용도별 시장 점유율 분석, 2024년 및 2033년
세계의 리드리스 페이스메이커 시장 : 최종 용도 전망별
시장 규모 및 예측 및 동향 분석(2021-2033년)
제7장 리드리스 페이스메이커 시장 부문 분석 : 지역별(2021-2033년)
지역별 시장 점유율 분석, 2024년 및 2030년
지역별 시장 대시보드
세계의 지역별 시장 개요
리드리스 페이스메이커 지역별 시장 점유율(2024년 및 2033년) :
북미
유럽
아시아태평양
라틴아메리카
중동 및 아프리카
제8장 경쟁 구도
주요 시장 진입 기업별 최근의 발전과 영향 분석
기업 분류
기업 개요
Abbott
Medtronic
EBR Systems, Inc.
Boston Scientific Corporation
MicroPort Scientific Corporation.
KSM
영문 목차
Leadless Pacemakers Market Summary
The global leadless pacemakers market size was estimated at USD 842.37 million in 2024 and is projected to reach USD 1,622.87 million by 2033, growing at a CAGR of 6.48% from 2025 to 2033. The increasing prevalence of cardiac disorders and associated risk factors is expected to drive demand for advanced device-based therapies.
According to an Oxford Academic article published in January 2025, globally, the age-standardized prevalence of cardiovascular disease is estimated at approximately 7,179 cases per 100,000 people, emphasizing the significant and growing burden of cardiac conditions. This high prevalence has amplified the need for innovative pacing solutions to manage rhythm disorders more safely and effectively. Leadless pacemakers have emerged as a transformative advancement in this field, offering a minimally invasive alternative to traditional pacemakers by eliminating the need for leads and surgical pockets.
Leadless pacemakers (PMs) have become a well-established therapeutic option over the past decade, offering significant advantages over traditional transvenous pacemakers. According to the NCBI article published in April 2025, eliminating leads and subcutaneous pockets, leadless devices such as Micra and Aveir substantially reduce the risk of infections and long-term complications such as electrode dislocation, pocket hematomas, pneumothorax, endocarditis, and venous obstruction. Data from the Micra PAR registry, which followed 1,809 patients for a mean of 51 months, reported a five-year major complication rate of only 4.5%, with most occurring within 30 days of implantation. Notably, no infections required device removal, and system revisions were rare, primarily for device upgrades or battery depletion.
Global Leadless Pacemakers Market Report Segmentation
This report forecasts revenue growth at global, regional & country levels and provides an analysis of the industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global leadless pacemakers market report based on chambers, brands, end use, and region:
Chambers Outlook (Revenue, USD Million, 2021 - 2033)
Single Chamber
Dual Chamber
Brands Outlook (Revenue, USD Million, 2021 - 2033)
Micra VR and VR2
Micra AV and AV2
Abbott Aveir DR
Abbott Aveir VR
Abbott Aveir AR
End Use Outlook (Revenue, USD Million, 2021 - 2033)
Hospitals
Outpatient Facilities
Regional Outlook (Revenue, USD Million, 2021 - 2033)
North America
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
South Korea
Australia
Thailand
Latin America
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
Table of Contents Chapter 1. Methodology And Scope
1.1. Market Segmentation & Scope
1.1.1. Segment scope
1.1.2. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR's internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.7. Research Assumptions
1.8. List of Secondary Sources
1.9. List of Primary Sources
Chapter 2. Leadless Pacemakers Market: Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Chambers Outlook
2.2.2. Brands Outlook
2.2.3. End Use Outlook
2.3. Competitive Insights
Chapter 3. Leadless Pacemakers Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing prevalence of cardiovascular diseases & other heart ailments
3.2.1.2. Reduced risk of infection and complications compared to traditional pacemakers
3.2.1.3. Technological advancements in electrophysiology & ineffective pharmacological treatments
3.2.1.4. Growing patients' demand for minimally invasive procedures
3.2.2. Market restraint analysis
3.2.2.1. High cost hampers widespread adoption of leadless pacemakers
3.2.2.2. Higher mortality risk
3.3. Global Leadless Pacemakers: Market Analysis Tools
3.3.1. Industry Analysis - Porter's
3.3.2. PESTLE Analysis
3.4. Case Study Analysis
3.5. Patient Epidemiology & Adoption Analysis (Comparative Analysis: 2023 vs 2024 vs 2025)
3.5.1. Eligible Patient Pool for Leadless Pacing (2023 Vs 2024 Vs 2025)
3.5.2. Patients Actually Receiving Leadless Pacemakers (2023 Vs 2024 Vs 2025)
3.5.3. Non-Implant / Contraindicated Population (2023 Vs 2024 Vs 2025)
3.5.4. Non-Implant / Contraindicated Population (2023 Vs 2024 Vs 2025)
3.5.5. Comparative Safety & Complication Rates (2023 Vs 2024 Vs 2025)
3.5.6. Patient Demographics & Comorbidity Mix (2023 Vs 2024 Vs 2025)
3.6. Technology Trends for Leadless Pacemakers Market
3.7. Competitive Factors and Strategies
3.7.1. Product Improvements & Innovations
3.7.2. Emerging Technologies
Chapter 4. Leadless Pacemakers Market Segment Analysis, By Chambers 2021-2033 (USD Million), Unit Volume (In Thousand)
4.1. Definition and Scope
4.2. Chambers Market Share Analysis, 2024 & 2033
4.3. Segment Dashboard
4.4. Global Leadless Pacemakers Market, By Chambers, 2021 - 2033
4.5. Leadless Pacemakers Market Size & Forecasts, By Chambers, 2021 - 2033 (USD Million)
4.6. Leadless Pacemakers Market Size & Forecasts, By Chambers, Unit Volume, 2021 - 2033 (In Thousand Units)
4.6.1. Single Chamber
4.6.1.1. Single Chamber Market Estimates and Forecasts 2021 To 2033 (USD Million)
4.6.2. Dual Chamber
4.6.2.1. Dual Chamber Market Estimates and Forecasts 2021 To 2033 (USD Million)
Chapter 5. Leadless Pacemakers Market Segment Analysis, By Brands 2021-2033 (USD Million), Unit Volume (In Thousand)
5.1. Definition and Scope
5.2. Brands Market Share Analysis, 2024 & 2033
5.3. Segment Dashboard
5.4. Global Leadless Pacemakers Market By Brands Outlook
5.5. Leadless Pacemakers Market Size & Forecasts, By Brands, 2021 - 2033 (USD Million)
5.6. Leadless Pacemakers Market Size & Forecasts, By Brands, Unit Volume, 2021 - 2033 (In Thousand Units)
5.7. Market Size & Forecasts and Trend Analyses, 2021 To 2033 For the Following
5.7.1. Micra VR and VR2
5.7.1.1. Micra VR and VR2 Market Estimates and Forecasts 2021 To 2033 (USD Million)
5.7.2. Micra AV and AV2
5.7.2.1. Micra AV and AV2 Market Estimates and Forecasts 2021 To 2033 (USD Million)
5.7.3. Abbott Aveir DR
5.7.3.1. Abbott Aveir DR Market Estimates and Forecasts 2021 To 2033 (USD Million)
5.7.4. Abbott Aveir VR
5.7.4.1. Abbott Aveir VR Market Estimates and Forecasts 2021 To 2033 (USD Million)
5.7.5. Abbott Aveir AR
5.7.5.1. Abbott Aveir AR Market Estimates and Forecasts 2021 To 2033 (USD Million)
Chapter 6. Leadless Pacemakers Market Segment Analysis, By End Use 2021-2033 (USD Million)
6.1. Definition and Scope
6.2. End Use Market Share Analysis, 2024 & 2033
6.3. Segment Dashboard
6.4. Global Leadless Pacemakers Market By End Use Outlook
6.5. Market Size & Forecasts and Trend Analyses, 2021 To 2033 For the Following
6.5.1. Hospitals
6.5.1.1. Market Estimates and Forecasts 2021 To 2033 (USD Million)
6.5.2. Outpatient Facilities
6.5.2.1. Market Estimates and Forecasts 2021 To 2033 (USD Million)
Chapter 7. Leadless Pacemakers Market Segment Analysis, By Region, 2021-2033 (USD Million)
7.1. Regional Market Share Analysis, 2024 & 2030
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. Leadless Pacemakers Market Share by Region, 2024 & 2033:
7.5. North America
7.5.1. North America Leadless Pacemakers Market, 2021 - 2033 (USD Million)
7.5.2. U.S.
7.5.2.1. Key Country Dynamics
7.5.2.2. Competitive Scenario
7.5.2.3. Regulatory Framework
7.5.2.4. U.S. Leadless Pacemakers Market, 2021 To 2033 (USD Million)
7.5.2.5. U.S. Leadless Pacemakers Market, Unit Volume, 2021 To 2033 (In Thousand Units)
7.5.3. Canada
7.5.3.1. Key Country Dynamics
7.5.3.2. Competitive Scenario
7.5.3.3. Regulatory Framework
7.5.3.4. Canada Leadless Pacemakers Market, 2021 To 2033 (USD Million)
7.5.3.5. Canada Leadless Pacemakers Market, Unit Volume, 2021 To 2033 (In Thousand Units)
7.5.4. Mexico
7.5.4.1. Key Country Dynamics
7.5.4.2. Competitive Scenario
7.5.4.3. Regulatory Framework
7.5.4.4. Mexico Leadless Pacemakers Market, 2021 To 2033 (USD Million)
7.5.4.5. Mexico Leadless Pacemakers Market, Unit Volume, 2021 To 2033 (In Thousand Units)
7.6. Europe
7.6.1. Europe Leadless Pacemakers Market, 2021 To 2033 (USD Million)
7.6.2. UK
7.6.2.1. Key Country Dynamics
7.6.2.2. Competitive Scenario
7.6.2.3. Regulatory Framework
7.6.2.4. UK Leadless Pacemakers Market, 2021 To 2033 (USD Million)
7.6.2.5. UK Leadless Pacemakers Market, Unit Volume, 2021 To 2033 (In Thousand Units)
7.6.3. Germany
7.6.3.1. Key Country Dynamics
7.6.3.2. Competitive Scenario
7.6.3.3. Regulatory Framework
7.6.3.4. Germany Leadless Pacemakers Market, 2021 To 2033 (USD Million)
7.6.3.5. Germany Leadless Pacemakers Market, Unit Volume, 2021 To 2033 (In Thousand Units)
7.6.4. Spain
7.6.4.1. Key Country Dynamics
7.6.4.2. Competitive Scenario
7.6.4.3. Regulatory Framework
7.6.4.4. Spain Leadless Pacemakers Market, 2021 To 2033 (USD Million)
7.6.4.5. Spain Leadless Pacemakers Market, Unit Volume, 2021 To 2033 (In Thousand Units)
7.6.5. France
7.6.5.1. Key Country Dynamics
7.6.5.2. Competitive Scenario
7.6.5.3. Regulatory Framework
7.6.5.4. France Leadless Pacemakers Market, 2021 To 2033 (USD Million)
7.6.5.5. France Leadless Pacemakers Market, Unit Volume, 2021 To 2033 (In Thousand Units)
7.6.6. Italy
7.6.6.1. Key Country Dynamics
7.6.6.2. Competitive Scenario
7.6.6.3. Regulatory Framework
7.6.6.4. Italy Leadless Pacemakers Market, 2021 To 2033 (USD Million)
7.6.6.5. Italy Leadless Pacemakers Market, Unit Volume, 2021 To 2033 (In Thousand Units)
7.6.7. Denmark
7.6.7.1. Key Country Dynamics
7.6.7.2. Competitive Scenario
7.6.7.3. Regulatory Framework
7.6.7.4. Denmark Leadless Pacemakers Market, 2021 To 2033 (USD Million)
7.6.7.5. Denmark Leadless Pacemakers Market, Unit Volume, 2021 To 2033 (In Thousand Units)
7.6.8. Sweden
7.6.8.1. Key Country Dynamics
7.6.8.2. Competitive Scenario
7.6.8.3. Regulatory Framework
7.6.8.4. Sweden Leadless Pacemakers Market, 2021 To 2033 (USD Million)
7.6.8.5. Sweden Leadless Pacemakers Market, Unit Volume, 2021 To 2033 (In Thousand Units)
7.6.9. Norway
7.6.9.1. Key Country Dynamics
7.6.9.2. Competitive Scenario
7.6.9.3. Regulatory Framework
7.6.9.4. Norway Leadless Pacemakers Market, 2021 To 2033 (USD Million)
7.6.9.5. Norway Leadless Pacemakers Market, Unit Volume, 2021 To 2033 (In Thousand Units)
7.7. Asia Pacific
7.7.1. Japan
7.7.1.1. Key Country Dynamics
7.7.1.2. Competitive Scenario
7.7.1.3. Regulatory Framework
7.7.1.4. Japan Leadless Pacemakers Market, 2021 To 2033 (USD Million)
7.7.1.5. Japan Leadless Pacemakers Market, Unit Volume, 2021 To 2033 (In Thousand Units)
7.7.2. China
7.7.2.1. Key Country Dynamics
7.7.2.2. Competitive Scenario
7.7.2.3. Regulatory Framework
7.7.2.4. China Leadless Pacemakers Market, 2021 To 2033 (USD Million)
7.7.2.5. China Leadless Pacemakers Market, Unit Volume, 2021 To 2033 (In Thousand Units)
7.7.3. India
7.7.3.1. Key Country Dynamics
7.7.3.2. Competitive Scenario
7.7.3.3. Regulatory Framework
7.7.3.4. India Leadless Pacemakers Market, 2021 To 2033 (USD Million)
7.7.3.5. India Leadless Pacemakers Market, Unit Volume, 2021 To 2033 (In Thousand Units)
7.7.4. South Korea
7.7.4.1. Key Country Dynamics
7.7.4.2. Competitive Scenario
7.7.4.3. Regulatory Framework
7.7.4.4. South Korea Leadless Pacemakers Market, 2021 To 2033 (USD Million)
7.7.4.5. South Korea Leadless Pacemakers Market, Unit Volume, 2021 To 2033 (In Thousand Units)
7.7.5. Thailand
7.7.5.1. Key Country Dynamics
7.7.5.2. Competitive Scenario
7.7.5.3. Regulatory Framework
7.7.5.4. Thailand Leadless Pacemakers Market, 2021 To 2033 (USD Million)
7.7.5.5. Thailand Leadless Pacemakers Market, Unit Volume, 2021 To 2033 (In Thousand Units)
7.7.6. Australia
7.7.6.1. Key Country Dynamics
7.7.6.2. Competitive Scenario
7.7.6.3. Regulatory Framework
7.7.6.4. Australia Leadless Pacemakers Market, 2021 To 2033 (USD Million)
7.7.6.5. Australia Leadless Pacemakers Market, Unit Volume, 2021 To 2033 (In Thousand Units)
7.8. Latin America
7.8.1. Latin America Leadless Pacemakers Market, 2021 - 2033 (USD Million)
7.8.2. Brazil
7.8.2.1. Key Country Dynamics
7.8.2.2. Competitive Scenario
7.8.2.3. Regulatory Framework
7.8.2.4. Brazil Leadless Pacemakers Market, 2021 To 2033 (USD Million)
7.8.2.5. Brazil Leadless Pacemakers Market, Unit Volume, 2021 To 2033 (In Thousand Units)
7.8.3. Argentina
7.8.3.1. Key Country Dynamics
7.8.3.2. Competitive Scenario
7.8.3.3. Regulatory Framework
7.8.3.4. Argentina Leadless Pacemakers Market, 2021 To 2033 (USD Million)
7.8.3.5. Argentina Leadless Pacemakers Market, Unit Volume, 2021 To 2033 (In Thousand Units)
7.9. MEA
7.9.1. MEA Leadless Pacemakers Market, 2021 - 2033 (USD Million)
7.9.2. South Africa
7.9.2.1. Key Country Dynamics
7.9.2.2. Competitive Scenario
7.9.2.3. Regulatory Framework
7.9.2.4. South Africa Leadless Pacemakers Market, 2021 To 2033 (USD Million)
7.9.2.5. South Africa Leadless Pacemakers Market, Unit Volume, 2021 To 2033 (In Thousand Units)
7.9.3. Saudi Arabia
7.9.3.1. Key Country Dynamics
7.9.3.2. Competitive Scenario
7.9.3.3. Regulatory Framework
7.9.3.4. Saudi Arabia Leadless Pacemakers Market, 2021 To 2033 (USD Million)
7.9.3.5. Saudi Arabia Leadless Pacemakers Market, Unit Volume, 2021 To 2033 (In Thousand Units)
7.9.4. UAE
7.9.4.1. Key Country Dynamics
7.9.4.2. Competitive Scenario
7.9.4.3. Regulatory Framework
7.9.4.4. UAE Leadless Pacemakers Market, 2021 To 2033 (USD Million)
7.9.4.5. UAE Leadless Pacemakers Market, Unit Volume, 2021 To 2033 (In Thousand Units)
7.9.5. Kuwait
7.9.5.1. Key Country Dynamics
7.9.5.2. Competitive Scenario
7.9.5.3. Regulatory Framework
7.9.5.4. Kuwait Leadless Pacemakers Market, 2021 To 2033 (USD Million)
7.9.5.5. Kuwait Leadless Pacemakers Market, Unit Volume, 2021 To 2033 (In Thousand Units)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company Categorization
8.3. Company Profiles
8.3.1. Abbott
8.3.1.1. Company overview
8.3.1.2. Financial performance
8.3.1.3. Product benchmarking
8.3.1.4. Strategic initiatives
8.3.2. Medtronic
8.3.2.1. Company overview
8.3.2.2. Financial performance
8.3.2.3. Product benchmarking
8.3.2.4. Strategic initiatives
8.3.3. EBR Systems, Inc.
8.3.3.1. Company overview
8.3.3.2. Financial performance
8.3.3.3. Product benchmarking
8.3.3.4. Strategic initiatives
8.3.4. Boston Scientific Corporation
8.3.4.1. Company overview
8.3.4.2. Financial performance
8.3.4.3. Product benchmarking
8.3.4.4. Strategic initiatives
8.3.5. MicroPort Scientific Corporation.
8.3.5.1. Company overview
8.3.5.2. Financial performance
8.3.5.3. Product benchmarking
8.3.5.4. Strategic initiatives
관련자료
